Clinical Trials Logo

Acne Vulgaris clinical trials

View clinical trials related to Acne Vulgaris.

Filter by:

NCT ID: NCT01038869 Completed - Acne Vulgaris Clinical Trials

Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH)

Start date: December 2009
Phase: Phase 4
Study type: Interventional

Residual post-inflammatory hyperpigmentation (PIH)from acne is disturbing to individuals with skin of color. Finacea has been anecdotally known to be beneficial in resolving PIH related to acne vulgaris. However, it has not been clinically tested for this purpose. The current study will investigate the efficacy and safety of Finacea in the treatment of acne vulgaris and PIH.

NCT ID: NCT01032499 Not yet recruiting - Boils Clinical Trials

Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir

E01GOU-INH0109
Start date: May 2010
Phase: Phase 3
Study type: Interventional

To measure the efficacy of Taro Elixir compare with Oxytetracycline in the treatment of boils or acne.

NCT ID: NCT01019603 Completed - Acne Vulgaris Clinical Trials

A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris

Start date: October 12, 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess systemic exposure of a new foam formulation of tazarotene, 0.1% compared with Tazorac Gel, 0.1%. The study design and dosing regimen are based on previous clinical studies with Tazorac Gel and Tazorac Cream.

NCT ID: NCT01017146 Completed - Acne Vulgaris Clinical Trials

A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301

Start date: October 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess safety and efficacy of a new foam formulation of tazarotene in subjects with acne vulgaris.

NCT ID: NCT01017120 Completed - Acne Vulgaris Clinical Trials

A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

Start date: October 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess safety and efficacy of a new foam formulation of tazarotene in subjects with acne vulgaris.

NCT ID: NCT01016977 Completed - Acne Vulgaris Clinical Trials

A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris

C0000-411
Start date: October 2009
Phase: Phase 4
Study type: Interventional

A single-blind (investigator-blinded), randomized, parallel group, single center study to evaluate the tolerability and efficacy of combination therapy with Duac Gel / 0.1% Tazorac Cream and Acanya Gel / 0.1% Tazorac Cream for the treatment of facial acne vulgaris.

NCT ID: NCT01015638 Completed - Acne Vulgaris Clinical Trials

Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications

Start date: August 2009
Phase: Phase 4
Study type: Interventional

This is a single-blind (blinded expert grader) study that will enroll 25-30 healthy volunteers without facial acne. On 1 side of the face, the subject will apply 1 of the 2 test products, clindamycin and benzoyl peroxide 5% or clindamycin phosphate and benzoyl peroxide 2.5% and the other side of the face will remain non-treated to serve as a control.

NCT ID: NCT01014689 Completed - Acne Vulgaris Clinical Trials

Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris

TEAM
Start date: August 2009
Phase: Phase 3
Study type: Interventional

Randomized, controlled, multi-center, double-blind, parallel-group comparison study in Subjects with moderate to severe acne vulgaris on the face. The purpose of this study is to demonstrate the efficacy of Adapalene 0.1% / Benzoyl Peroxide (BPO) 2.5% Gel associated with Lymecycline 300mg Capsules compared to Adapalene 0.1% /Benzoyl Peroxide 2.5% Vehicle Gel associated with Lymecycline 300mg Capsules, in the treatment of moderate to severe acne vulgaris. The safety of the two treatment regimens will also be evaluated.

NCT ID: NCT00991198 Completed - Atopic Dermatitis Clinical Trials

The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage

Start date: September 2009
Phase: Phase 2
Study type: Interventional

This study is an evaluation of the role of topical dissolved oxygen to lessen visible signs of photodamage using a select regimen of topical dissolved oxygen containing cosmeceutical products. Evaluation of the overall skin tolerability of topical dissolved oxygen (safety) utilizing the regimen of products.

NCT ID: NCT00974870 Completed - Acne Scars Clinical Trials

A Pilot Study Testing the Efficacy of a Needling Device for the Treatment of Acne Scars

Start date: November 2009
Phase: N/A
Study type: Interventional

The primary objective of this study is to determine the efficacy of a needling device for treatment of acne scars.